Keywords: تیکاگرلور; Ticagrelor; Isomerization; Triazole;
مقالات ISI تیکاگرلور (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: تیکاگرلور; Atorvastatin; Ticagrelor; Ischemia-reperfusion injury; Forearm blood flow;
Keywords: تیکاگرلور; Angioplasty; clopidogrel; distal protection; drug-eluting stent; intravascular ultrasound; laser; MRCP; optical coherence tomography; percutaneous coronary intervention; prasugrel; pressure wire; radial; rotablation; stent; thrombectomy; ticagrelor;
Keywords: تیکاگرلور; Antiplatelets; Prasugrel; Ticagrelor; Acute coronary syndrome; Prognosis;
Keywords: تیکاگرلور; ACC/AHA; American College of Cardiology, American Heart Association; ACS; acute coronary syndrome(s); CABG; coronary artery bypass graft surgery; CAD; coronary artery disease; CV; cardiovascular; DAPT; dual antiplatelet therapy; ESC; European Society of C
Keywords: تیکاگرلور; Acute coronary syndrome; Antiplatelet therapy; Ticagrelor; Clopidogrel; In-stent thrombosis; Target vessel revascularization;
Keywords: تیکاگرلور; Médicaments antiplaquettaires; Clopidogrel; Prasugrel; Aspirine; Ticagrelor; Transfusion plaquettaire; Hémorragie; Antidote; P2Y12; Antiplatelet agents; Clopidogrel; Prasugrel; Aspirine; Ticagrelor; Platelet transfusion; Bleeding; Antidote; P2Y12;
Keywords: تیکاگرلور; Acute coronary syndromes; Antiplatelet treatment; Guidelines; Myocardial infarction; Percutaneous Coronary intervention; Clopidogrel; Ticagrelor; Prasugrel;
Keywords: تیکاگرلور; ACS; acute coronary syndrome; ADP; adenosine diphosphate; Aggmax; maximal extent of aggregation; AMI; acute myocardial infarction; BARC; Bleeding Academic Research Consortium; CKD; chronic kidney disease; ESRD; end stage renal disease; HD; hemodialysis; H
Facile alkylation of 4-nitrobenzotriazole and its platelet aggregation inhibitory activity
Keywords: تیکاگرلور; Alkylation of nitrobenzotriazole; 4-Nitrobenzotriazole; 3-Nitrobenzene-1,2-diamine; Platelets; Ticagrelor;
Keywords: تیکاگرلور; Pretreatment; Preloading; Clopidogrel; Prasugrel; Ticagrelor; Cangrelor;
Keywords: تیکاگرلور; aortic stenosis; surgical aortic valve replacement; transcatheter aortic valve replacement; balloon-inflatable prosthesis; self-inflating prosthesis; surgical risk; Society of Thoracic Surgeons; Cardiothoracic Surgical Trials Network; PARTNER trials; NOTI
Keywords: تیکاگرلور; Dual antiplatelet therapy; Interaction/degradation products; Physico-chemical characterization; Polypill; Preformulation; Ticagrelor; Solid-state;
Keywords: تیکاگرلور; Ticagrelor; Prasugrel; Clopidogrel; Neointima formation; Endothelium; Drug-eluting stents;
Keywords: تیکاگرلور; Clopidogrel; Prasugrel; Ticagrelor; Dual antiplatelet therapy; Coronary stenting; Bleeding; Prediction; VerifyNow assay;
Keywords: تیکاگرلور; High residual platelet reactivity; In-stent thrombosis; Prasugrel; Ticagrelor; Acute coronary syndrome;
Keywords: تیکاگرلور; Ticagrelor; Clopidogrel; Coronary artery disease; Platelet function tests;
Keywords: تیکاگرلور; Ticagrelor; Clopidogrel; Prasugrel; Drug resistance; Percutaneous coronary intervention;
Keywords: تیکاگرلور; Ticagrelor; Clopidogrel; Serum uric acid; Platelet aggregation
Keywords: تیکاگرلور; acute coronary syndrome; antiplatelet therapy; clopidogrel; outcomes; ticagrelor
Keywords: تیکاگرلور; Paediatric haemostasis; Platelet pharmacology; ADP receptors; Ticagrelor
Keywords: تیکاگرلور; Ticagrelor; Clopidogrel; Diabetes mellitus; Hispanic;
Keywords: تیکاگرلور; Rosuvastatin; Ticagrelor; Clopidogrel; CythocromesASA = acetylsalicylic acid, DAPT = dual antiplatelet therapy; PCI = percutaneous coronary intervention, HRPR = high-residual on-treatment platelet reactivity; MEA = multiple electrode aggregometry, ADP = a
Keywords: تیکاگرلور; Therapeutic window; Personalized anti-platelet therapy; Ticagrelor
Keywords: تیکاگرلور; Medicamento antiplaquetario; Aspirina; Clopidogrel; Prasugrel; Ticagrelor; Resistencia biológica
Keywords: تیکاگرلور; Acute coronary syndrome; Myocardial infarction; Unstable angina; Clopidogrel; Ticagrelor; Prasugrel;
Keywords: تیکاگرلور; Platelet inhibition; platelet reactivity; high on-treatment platelet reactivity (HTPR); platelet aggregation assay; ticagrelor; clopidogrel; antiplatelet therapy; thrombosis; kidney failure; hemodialysis (HD); end-stage renal disease (ESRD);
Keywords: تیکاگرلور; Ticagrelor; LC stability-indicating assay method; Degradation kinetic; Electrospray orbitrap mass spectrometry; Degradation pathways
Keywords: تیکاگرلور; Flavonoid-drug interaction; Ticagrelor; Human serum albumin; Competitive binding; Spectroscopy;
Keywords: تیکاگرلور; Clopidogrel resistance; Platelet reactivity; Stent thrombosis; Prasugrel; Ticagrelor;
Keywords: تیکاگرلور; ACS; CABG; Surgery revascularization; Dual antiplatelet therapy; Ticagrelor; Clopidogrel;
Keywords: تیکاگرلور; Aspirina; Clopidogrel; Genética; Individualización; Factores de riesgo; Resistencia; Guías; Prasugrel; TicagrelorAspirin; Clopidogrel; Genetics; Individualization; Risk factors; Resistance; Guidelines; Prasugrel; Ticagrelor
Keywords: تیکاگرلور; Platelet function testing; Individualized antiplatelet treatment; Clopidogrel; Prasugrel; Ticagrelor; Acute coronary syndrome;
Keywords: تیکاگرلور; CYP3A; midazolam; pharmacokinetics; ticagrelor;
Keywords: تیکاگرلور; Vorapaxar; Ticagrelor; Trial conduct; Data censoring; Clinical trials
Keywords: تیکاگرلور; Platelet aggregation; Ticagrelor; Prasugrel; Bleeding; Myocardial infarction
Ticagrelor
Keywords: تیکاگرلور; Ticagrelor; Adenosine; P2Y12 antagonist; Inflammation; Acute coronary syndrome;
Pharmacogenomic Testing to Select Antiplatelet Therapyâ
Keywords: تیکاگرلور; acute coronary syndrome; antiplatelet therapy; clopidogrel; pharmacogenomics; platelet function testing; platelet reactivity; prasugrel; thienopyridine; ticagrelor;
Clash of Oral P2Y12 Receptor Inhibitors in Acute Coronary Syndromesâ
Keywords: تیکاگرلور; de-escalation; myocardial infarction; outcome; prasugrel; primary percutaneous coronary intervention; ticagrelor;
Effect of intravenous fentanyl on ticagrelor absorption and platelet inhibition among patients undergoing percutaneous coronary intervention: Design, rationale, and sample characteristics of the PACIFY randomized trial
Keywords: تیکاگرلور; Fentanyl; PCI; Platelet inhibition; Ticagrelor; Pharmacokinetics; Pharmacodynamics;
The mortality benefit seen with the newer more potent oral P2Y12 inhibitors prasugrel and ticagrelor over clopidogrel is dependent on the underlying risk: A class effect as suggested by a meta-regression analysis
Keywords: تیکاگرلور; P2Y12 inhibitor; Prasugrel; Ticagrelor; Acute coronary syndrome (ACS); Meta-regression; Mortality;
Ticagrelor versus clopidogrel in East Asian patients with acute coronary syndrome: Systematic review and meta-analysis
Keywords: تیکاگرلور; ACS; acute coronary syndrome; CABG; coronary artery bypass grafting; CI; confidence interval; PLATO; Platelet Inhibition and Patient Outcomes; Ticagrelor; Clopidogrel; Acute coronary syndrome; East Asian;
Impact of adenosine A2a receptor polymorphism rs5751876 on platelet reactivity in ticagrelor treated patients
Keywords: تیکاگرلور; Ticagrelor; Platelet activation; Adenosine A2a receptor; Single nucleotide polymorphism; Percutaneous coronary intervention;
Ticagrelor protects against AngII-induced endothelial dysfunction by alleviating endoplasmic reticulum stress
Keywords: تیکاگرلور; Ticagrelor; Endothelial dysfunction; AngII; Endoplasmic reticulum stress;
Bleeding in advanced CKD patients on antithrombotic medication - A critical appraisal
Keywords: تیکاگرلور; acetylsalicylic acid; clopidogrel; prasugrel; ticagrelor; dabigatran; rivaroxaban; apixaban; warfarin; heparin; low molecular weight heparin; proton pump inhibitors; Bleeding; Chronic kidney disease; Management; Risk;
Ticagrelor, a P2Y12 antagonist, attenuates vascular dysfunction and inhibits atherogenesis in apolipoprotein-E-deficient mice
Keywords: تیکاگرلور; Atherosclerosis; Inflammation; Endothelial function; P2Y12; Ticagrelor; Ach; acetylcholine; ACS; acute coronary syndrome; ADP; adenosine diphosphate; apoEâ/â; apolipoprotein E-deficient; Ctrl; control; HUVEC; human umbilical vein endothelial cell; ICA
Effects of Ticagrelor, Prasugrel, or Clopidogrel on Endothelial Function and Other Vascular Biomarkers
Keywords: تیکاگرلور; adenosine; endothelial function; P2Y12 inhibitors; prasugrel; ticagrelor; ACS; acute coronary syndrome; ANOVA; analysis of variance; ENT1; equilibrative nucleoside transporter 1; FMD; flow-mediated dilation; LD; loading dose; MD; maintenance dose; RHI; re
Application of Quality by Design to optimize a stability-indicating LC method for the determination of ticagrelor and its impurities
Keywords: تیکاگرلور; Quality by Design; Drug impurities; Ticagrelor; HPLC; AQbD;
Ticagrelor for stroke prevention in patients with vascular risk factors: A systematic review and meta-analysis
Keywords: تیکاگرلور; Ticagrelor; Ischemic stroke; Secondary prevention; Vascular;
Anemia in patients with acute coronary syndromes treated with prasugrel or ticagrelor: Insights from the RENAMI registry
Keywords: تیکاگرلور; Anemia; Acute coronary syndromes; Prognosis; Ticagrelor; Prasugrel;